A successful antipsychotic combination trial. Quo Vadis?

Acta Psychiatrica Scandinavica

Volumn 110, Issue 4, 2004, Pages 241-242

  Stahl, Stephen ^a   Freudenreich, Oliver ^a   Goff, Donald ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; CLOZAPINE; DOPAMINE 3 RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

CLINICAL TRIAL; DRUG EFFICACY; EDITORIAL; HUMAN; MENTAL HEALTH CARE; POLYPHARMACY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; PSYCHOTIC DISORDERS; SULPIRIDE;

EID: 4644291262     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2004.00370.x     Document Type: Editorial

References (13)

1. MUNRO J, MATTHIASSON P, OSBORNE S et al. Amisulpiride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine. Acta Psychiatr Scand 2004;110:292-298.
2. FREUDENREICH O, GOFF DC. Antipsychotic combination therapy in schizophrenia. A review of efficacy and risk of current combinations. Acta Psychiatr Scand 2002;106:323-330.
3. STAHL SM. Antipsychotic polypharmacy: evidence based or eminence based? Acta Psychiatr Scand 2002;106:321-322.
4. FREUDENREICH O, GOFF DC. Polypharmacy in schizophrenia: a fuzzy concept. J Clin Psychiatry 2003;64:1132.
5. STAHL SM. Reply to polypharmacy in schizophrenia: a fuzzy concept. J Clin Psychiatry 2003;64:1132-1133.
6. GOFF DC, FREUDENREICH O. Focus on polypharmacy in schizophreni: does anyone truly benefit? Int J Neuropsychopharmacol 2004;7:109-111.
7. STAHL SM. Focus on a antipsychotic polypharmacy: evidence based prescribing or prescribing based evidence? Int J Neuropsychopharmacol 2004;7:113-116.
8. STAHL SM. Antipsychotic polypharmacy: squandering precious resources? J Clin Psychiatry 2002;63:93-94.
9. STAHL SM. Antipsychotic polypharmacy, part 1: therapeutic option or dirty little secret? J Clin Psychiatry 1999;60:425-426.
10. STAHL SM. Antipsychotic polypharmacy, part 2: tips on use and misuse. J Clin Psychiatry 1999;60:506-507.
11. STAHL SM. Antipsychotic polypharmacy: squandering precious resources? J Clin Psychiatry 2002;63:93-94.
12. STAHL SM, GRADY MM. A critical review of atypical anti-psychotic utilization: comparing monotherapy with polypharmacy and augmentation. Curr Med Chem 2004;11:313-327.
13. SHILOH R, ZEMISHLANY Z, AIZENBERG D et al. Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study. Br J Psychiatry 1997;171:569-573.